ats-clinicalprobs.bsky.social
ATS Assembly on pulmonary patient care/education/research/QI ILD, COPD, CF, IP, surgery, bronchiectasis, transplant, PFTs + more
👤 Joined on 06 December 2024
Followers
Following
Total Posts
@ats-clinicalprobs.bsky.socialHave questions about home oxygen? Need a refresher on the data or practical tips to make you and your patients' lives easier? We've got you covered! Sign up for our joint webinar with the ATS Clinical Problems assembly on Home Oxygen Prescription and Delivery Systems. 11/21/25 at 1600EST!
Show PostOn Sept 9 at 11am ET, join our @ats-rsf.bsky.social for a Journal Club on "Asthma and Lower Airway Disease: Neuroplasticity and Neuroimmune Interactions in Fatal Asthma". Register here: thoracic.zoom.us/meeting/regi...
Show Post📣Call for Papers!📣 We aim to showcase work that investigates the underlying mechanisms for lung repair in health and disease, including lung development 📆Deadline: December 31, 2025 🔬Learn More Here: tinyurl.com/ye24jb76 🖱️Submit here: tinyurl.com/yahzwj8k @atscommunity.bsky.social #medsky
Show PostThe ATS's journals have a big impact, and we've got the numbers to prove it! @atsscholar.bsky.social @atsblueeditor.bsky.social @ajrcmb.bsky.social @annalsats.bsky.social Check out the ATS's journals: www.atsjournals.org
Show PostNerandomilast slows FVC deterioration in IPF patients without/with background #antifibrotic therapy. - No additional protection from IPF exacerbation - Pirfenidone decreases plasma levels of Nerandomilast by 50% as opposed to nintedanib. #pulmonaryfibrosis #ATS2025 www.nejm.org/doi/full/10....
Show Post